Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma: Both or neither?

American Journal of Gastroenterology

Volumn 101, Issue 3, 2006, Pages 524-532

  Farinati, Fabio ^a   Marino, Dario ^b   De Giorgio, Massimo ^b   Baldan, Anna ^b   Cantarini, Maria ^b   Cursaro, Carmela ^b   Rapaccini, Gianludovico ^b   Del Poggio, Paolo ^b   Di Nolfo, Maria Anna ^b   Benvegnù, Luisa ^b   Zoli, Marco ^b   Borzio, Franco ^b   Bernardi, Mauro ^b   Trevisani, Franco ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CELL ADHESION MOLECULE; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TRANSPLANTATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISCRIMINANT ANALYSIS; FEMALE; GENE OVEREXPRESSION; HEALTH CENTER; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PAIN; PATHOGENESIS; PATHOLOGIST; PORTAL VEIN THROMBOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SCORING SYSTEM; SERUM; SEX DIFFERENCE; STATISTICAL ANALYSIS; TUMOR IMMUNOLOGY; WEIGHT REDUCTION;

AGED; ALPHA-FETOPROTEINS; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33644787374     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00443.x     Document Type: Article

References (35)

1. Talerman A Haije WG Baggerman L Serum αfetoprotein in patients with germ cell tumors of the gonads and extragonadal sites: Correlation between endodermal sinus (yolk sac) tumor and raised serum αFP Cancer 1980 46 2 380 5
2. Chen J Rocken C Treiber G et al. Clinical implications of αfetoprotein expression in gastric adenocarcinoma Dig Dis 2003 21 4 357 62
3. Hiroshima K Iyoda A Toyozaki T et al. Alpha-fetoprotein-producing lung carcinoma: Report of three cases Pathol Int 2002 52 1 46 53
4. Daniele B Bencivenga A Megna AS et al. αfetoprotein and ultrasonography for hepatocellular carcinoma Gastroenterology 2004 127 108 12
5. Di Bisceglie AM Issues in screening and surveillance for hepatocellular carcinoma Gastroenterology 2004 127 104 7
6. Gupta S Bent S Kohlwes J Test characteristics of αfetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C Ann Intern Med 2003 139 46 9
7. Trevisani F D'Intino PE Morselli-Labate AM et al. Serum αfetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HbsAg and anti-HCV status J Hepatol 2001 34 570 5
8. Colombo M Screening for cancer in viral hepatitis Clin Liver Dis 2001 5 109 22
9. Cottone M Turri M Caltagirone M et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: An 8 year prospective study by ultrasound and αFP J Hepatol 1994 21 1029 34
10. Bruix J Sherman M Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 2001 35 3 421 30
11. Commissione Epatocarcinoma dell'Associazione Italiana per lo Studio del Fegato Epatocarcinoma: Linee Guida per la Diagnosi e la Terapia Bologna Tipografia Moderna 1998 235 86
12. Sherman M αfetoprotein: An obituary J Hepatol 2001 34 4 603 5
13. Colombo M Predictive value of serum alpha-fetoprotein in cirrhosis Hepatology 1994 20 6 1650
14. Nomura F Ohnishi K Tanabe Y Clinical features and prognosis of hepatocellular carcinoma with reference to serum αfetoprotein levels Cancer 1989 64 1700 7
15. Tangkijvanich P Anukulkarnkusol N Suwangool P et al. Clinical characteristics and prognosis of hepatocellular carcinoma. Analysis based in serum αfetoprotein levels J Clin Gastroenterol 2000 31 4 302 8
16. Peng SY Chen WJ Lai PL et al. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and beta-catenin mutations Int J Cancer 2004 112 1 44 50
17. Trevisani F Cantarini MC Labate AM et al. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: Effects on cancer staging and patient survival Am J Gastroenterol 2004 99 8 1470 6
18. Trevisani F De NS Rapaccini G et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: Effects on cancer stage and patient survival (Italian experience) Am J Gastroenterol 2002 97 3 734 44
19. The Cancer of the Liver Italian Program (CLIP) Investigators: A new prognostic system for hepatocellular carcinoma; A retrospective study of 435 patients Hepatology 1998 28 751 5
20. Llovet JM Bru C Bruix J Prognosis of hepatocellular carcinoma: The BCLC staging classification Semin Liver Dis 1999 19 3 329 38
21. Perrone F Gallo C Daniele B et al. Tamoxifen in the treatment of hepatocellular carcinoma: A 5-year results of the CLIP-1 multicentre randomised controlled trial Curr Pharm Des 2002 8 11 1013 9
22. Nowak AK Stockler MR Chow PK et al. Use of Tamoxifen in advanced-stage hepatocellular carcinoma Cancer 2005 103 1408 14
23. Kang JY Lee TP Yap I et al. Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers J Gastroenterol Hepatol 1992 7 463 8
24. Arguedas MR Chen VK Eloubeidi MA et al. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: A cost-utility analysis Am J Gastroenterol 2003 98 679 90
25. Qin LX Tang ZY Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: A review of the literature J Cancer Res Clin Oncol 2004 130 9 497 513
26. Cui J Dong BW Liang P et al. Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection World J Gastroenterol 2004 10 10 1533 6
27. Guo XS Shao XD Liu MP et al. Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma World J Gastroenterol 2002 8 6 1059 62
28. Garcia ES Lawson D Cotsonis G et al. Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): Prognostic significance Appl Immunohistochem Mol Morphol 2002 10 3 210 7
29. Ravazoula P Tsamandas AC Kardamakis D et al. The potential role of bcl-2 mRNA and protein expression in hepatocellular carcinomas Anticancer Res 2002 22 3 1799 805
30. Semenkova L Dudich E Dudich I et al. Alpha-fetoprotein positively regulates cytochrome c-mediated caspase activation and apoptosome complex formation Eur J Biochem 2003 270 21 4388 99
31. Dudich E Semenkova L Dudich I et al. Alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases Eur J Biochem 1999 266 3 750 61
32. Li MS Li PF He SP et al. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line World J Gastroenterol 2002 8 3 469 75
33. Li MS Li PF Yang FY et al. The intracellular mechanism of alphafetoprotein promoting the proliferation of NIH 3T3 cells Cell Res 2002 12 2 151 6
34. Torres JM Laborda J Naval J et al. Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformation Mol Immunol 1989 26 9 851 7
35. Wang XW Xie H Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro Life Sci 1999 64 1 17 23